These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32825313)

  • 1. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies.
    Fusar-Poli L; Cavone V; Tinacci S; Concas I; Petralia A; Signorelli MS; Díaz-Caneja CM; Aguglia E
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid treatment for the symptoms of autism spectrum disorder.
    Aran A; Cayam Rand D
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of cannabinoids as treatments for autism spectrum disorders.
    Nezgovorova V; Ferretti CJ; Taylor BP; Shanahan E; Uzunova G; Hong K; Devinsky O; Hollander E
    J Psychiatr Res; 2021 May; 137():194-201. PubMed ID: 33689997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.
    Holdman R; Vigil D; Robinson K; Shah P; Contreras AE
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):451-463. PubMed ID: 34432543
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
    Silva EAD; Medeiros WMB; Torro N; Sousa JMM; Almeida IBCM; Costa FBD; Pontes KM; Nunes ELG; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2022 Jun; 44():e20200149. PubMed ID: 34043900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities.
    Barchel D; Stolar O; De-Haan T; Ziv-Baran T; Saban N; Fuchs DO; Koren G; Berkovitch M
    Front Pharmacol; 2018; 9():1521. PubMed ID: 30687090
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review.
    Ibsen EWD; Thomsen PH
    Nord J Psychiatry; 2024 Jul; ():1-8. PubMed ID: 39037073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal Studies.
    Miranda A; Peek E; Ancoli-Israel S; Young JW; Perry W; Minassian A
    Behav Sleep Med; 2024 Mar; 22(2):217-233. PubMed ID: 37401160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of cannabinoids in epilepsy treatment.
    De Caro C; Leo A; Citraro R; De Sarro C; Russo R; Calignano A; Russo E
    Expert Rev Neurother; 2017 Nov; 17(11):1069-1079. PubMed ID: 28845714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.
    Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):741-753. PubMed ID: 29511052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats.
    Zamberletti E; Gabaglio M; Woolley-Roberts M; Bingham S; Rubino T; Parolaro D
    Front Cell Neurosci; 2019; 13():367. PubMed ID: 31447649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report.
    Ponton JA; Smyth K; Soumbasis E; Llanos SA; Lewis M; Meerholz WA; Tanguay RL
    J Med Case Rep; 2020 Sep; 14(1):162. PubMed ID: 32958062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.
    Rossignol DA; Frye RE
    Front Pediatr; 2014; 2():87. PubMed ID: 25202686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.